This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Pauayiotis Alexandron Procopiou: Innovator in Indazole Compounds
Introduction
Pauayiotis Alexandron Procopiou is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on indazole compounds. His expertise and dedication to research have led to the development of valuable therapeutic solutions.
Latest Patents
Procopiou holds a patent for "Compounds - Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy." This patent highlights his focus on creating compounds that can be utilized in medical treatments, showcasing his commitment to advancing healthcare.
Career Highlights
Throughout his career, Procopiou has been associated with Glaxo Group Limited, a prominent player in the pharmaceutical industry. His work at this company has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Yannick Maurice Lacroix and Simon Teanby Hodgson. Their collaborative efforts have likely enhanced the innovative environment in which Procopiou operates, fostering creativity and progress in their projects.
Conclusion
Pauayiotis Alexandron Procopiou is a distinguished inventor whose work on indazole compounds has the potential to impact therapeutic practices significantly. His contributions to the pharmaceutical field exemplify the importance of innovation in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
